U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
PASOTUXIZUMAB
INN   WHO-DD  
INN  
Official Name English
IMMUNOGLOBULIN SCFV-SCFV, ANTI-(HOMO SAPIENS FOLH1 (FOLATE HYDROLASE, PROSTATE SPECIFIC MEMBRANE ANTIGEN, PSMA))/ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON)), HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODY BISPECIFIC SINGLE CHAIN
Preferred Name English
Pasotuxizumab [WHO-DD]
Common Name English
pasotuxizumab [INN]
Common Name English
Code System Code Type Description
CAS
1442657-12-6
Created by admin on Mon Mar 31 22:46:02 GMT 2025 , Edited by admin on Mon Mar 31 22:46:02 GMT 2025
PRIMARY
INN
9937
Created by admin on Mon Mar 31 22:46:02 GMT 2025 , Edited by admin on Mon Mar 31 22:46:02 GMT 2025
PRIMARY
FDA UNII
9J6SW7G28J
Created by admin on Mon Mar 31 22:46:02 GMT 2025 , Edited by admin on Mon Mar 31 22:46:02 GMT 2025
PRIMARY
EVMPD
SUB181116
Created by admin on Mon Mar 31 22:46:02 GMT 2025 , Edited by admin on Mon Mar 31 22:46:02 GMT 2025
PRIMARY
SMS_ID
100000166788
Created by admin on Mon Mar 31 22:46:02 GMT 2025 , Edited by admin on Mon Mar 31 22:46:02 GMT 2025
PRIMARY
NCI_THESAURUS
C103827
Created by admin on Mon Mar 31 22:46:02 GMT 2025 , Edited by admin on Mon Mar 31 22:46:02 GMT 2025
PRIMARY
ACTIVE MOIETY
PASOTUXIZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966